Certificate Name | Certificate University | Certificate Date |
---|---|---|
الدكتوراه في Cancer biology | State University of New York at Buffalo | 04/08/2022 |
Research Name | Research Date Submitted | Research Link |
---|---|---|
Mutant Kras as a Biomarker Plays a Favorable Role in FL118-Induced Apoptosis, Reactive Oxygen Species (ROS) Production and Modulation of Survivin, Mcl-1 and XIAP in Human Bladder Cancer | 2022-11-01 12:00:00 AM | Mutant Kras as a Biomarker Plays a Favorable Role in FL118-Induced Apoptosis, Reactive Oxygen Species (ROS) Production and Modulation of Survivin, Mcl-1 and XIAP in Human Bladder Cancer |
Molecular Glues: Capable Protein-Binding Small Molecules That Can Change Protein-Protein Interactions and Interactomes for the Potential Treatment of Human Cancer and Neurodegenerative Diseases | 2022-06-01 12:00:00 AM | Molecular Glues: Capable Protein-Binding Small Molecules That Can Change Protein-Protein Interactions and Interactomes for the Potential Treatment of Human Cancer and Neurodegenerative Diseases |
FL118, acting as a 'molecular glue degrader', binds to dephosphorylates and degrades the oncoprotein DDX5 (p68) to control c-Myc, survivin and mutant Kras against colorectal and pancreatic cancer with | 2022-05-01 12:00:00 AM | FL118, acting as a 'molecular glue degrader', binds to dephosphorylates and degrades the oncoprotein DDX5 (p68) to control c-Myc, survivin and mutant Kras against colorectal and pancreatic cancer with |
Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1?, HIF2?, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma | 2021-08-01 12:00:00 AM | Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1?, HIF2?, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma |
Kras mutation subtypes distinctly affect colorectal cancer cell sensitivity to FL118, a novel inhibitor of survivin, Mcl-1, XIAP, cIAP2 and MdmX | 2021-07-01 12:00:00 AM | Kras mutation subtypes distinctly affect colorectal cancer cell sensitivity to FL118, a novel inhibitor of survivin, Mcl-1, XIAP, cIAP2 and MdmX |
Cancer therapeutics using survivin BIRC5 as a target: what can we do after over two decades of study? | 2019-08-01 12:00:00 AM | Cancer therapeutics using survivin BIRC5 as a target: what can we do after over two decades of study? |
Role of Chromatin Damage and Chromatin Trapping of FACT in Mediating the Anticancer Cytotoxicity of DNA-Binding Small-Molecule Drugs | 2018-03-01 12:00:00 AM | Role of Chromatin Damage and Chromatin Trapping of FACT in Mediating the Anticancer Cytotoxicity of DNA-Binding Small-Molecule Drugs |
Tumor p38MAPK signaling enhances breast carcinoma vascularization and growth by promoting expression and deposition of pro-tumorigenic factors | 2017-06-01 12:00:00 AM | Tumor p38MAPK signaling enhances breast carcinoma vascularization and growth by promoting expression and deposition of pro-tumorigenic factors |
Place Name | Experince | From | To |
---|
Cource Name | place | Cource Date |
---|---|---|
O EFFECTIVE TEACHING WORKSHOP SERIES, CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTE (CTSA), UNIVERSITY AT BUFFALO. | 03/09/2020 | |
O ACADEMIC LEADERSHIP DEVELOPMENT WORKSHOP, ACADEMIC LEADERSHIP CENTER, MINISTRY OF EDUCATION AT KINGDOM OF SAUDI ARABIA, WASHINGTON D.C. | Ministry of Education | 16/05/2019 |
O STATISTICAL WORKSHOP SERIES, CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTE (CTSA), UNIVERSITY AT BUFFALO. | 09/08/2018 |
Award/invention | Doner Place | Date |
---|
Committee Name | Committee Type | Join Date |
---|---|---|
لجنة الأنشطة الطلابية | داخل الجامعة | 04/09/2022 |
CV File |
---|